MOORE, Z., J.V. SORIANO, Andrea POKORNÁ, L. SCHOONHOVEN, H. VUAGNAT, A. MARKOVA and J. KRISTENSEN. The joint EPUAP & EWMA pressure ulcer prevention & patient safety advocacy project. Wounds UK. London: Wounds UK Ltd., 2017, vol. 13, No 3, p. 16-20. ISSN 1746-6814.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The joint EPUAP & EWMA pressure ulcer prevention & patient safety advocacy project
Authors MOORE, Z. (372 Ireland), J.V. SORIANO (724 Spain), Andrea POKORNÁ (203 Czech Republic, guarantor, belonging to the institution), L. SCHOONHOVEN (840 United States of America), H. VUAGNAT (756 Switzerland), A. MARKOVA (826 United Kingdom of Great Britain and Northern Ireland) and J. KRISTENSEN (826 United Kingdom of Great Britain and Northern Ireland).
Edition Wounds UK, London, Wounds UK Ltd. 2017, 1746-6814.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30307 Nursing
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/17:00098409
Organization unit Faculty of Medicine
Keywords in English EPUAP; EWMA; Key performance indicator; Patient safety; Pressure ulcer
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 22/3/2018 15:47.
Abstract
Background: Pressure ulcers (PUs) are a common, costly, debilitating problem across all healthcare sectors, despite significant investment in education and training and use of human resources, equipment, and technological advancements. In recognising the persistent problem of PUs, the European Wound Management Association (EWMA) and the European Pressure Ulcer Advisory Panel (EPUAP) have created a group to work collectively on a specific project advocating for the prevention of PUs to be considered as a major health care and patient safety issue. Aim: The overall aim of the project is to establish a joint EPUAP-EWMA working group on PU prevention and engage in patient safety agendas at the European level as well as at the national level in selected European countries. Discussion: We are seeking to place prevention of PUs as a high priority on the patient safety agenda within the European Union (EU). To achieve this, given the lack of agreed methodology for incidence monitoring, we advocate for the use of standardised monitoring of PU prevalence, with targeted prevention measures to reduce prevalence, made available across the continuum of care. Conclusion: Adopting PU prevalence as a key measurement tool across the wider health care sector in the EU, will ensure that both adequate monitoring of prevalence and use of prevention can be achieved.
PrintDisplayed: 23/7/2024 13:12